This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


The race is on to find ways to help consumers reduce their risk of developing cardiovascular disease (CVD). Increasingly, the world is waking up to the fact that dietary supplements have an important role to play in achieving this. Aronox® is an extract of aronia berry that delivers heart health benefits supported by several published peer-reviewed clinical trials, with significant improvements observed within just one month. Download this whitepaper to learn how to harness the benefits of Aronox to create supplements that address biomarkers for CVD and help people live longer, healthier lives.

  • CVD is the world's leading cause of death, killing an estimated 17.5 million people annually.
  • The phenolic compounds in the aronia berry have shown to decrease plasma lipid levels.
  • Research into Aronox's benefits continues, with a particular emphasis on endothelial function.

The content of this message is intended for business-to-business communication only within the United States. The information provided must be checked with the proper regulatory authorities before being used as a claim.